The current financial score of SANUWAVE Health Inc is 6.26. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 9.74M, representing a year-over-year decrease of 3.13%, while its net profit experienced a year-over-year decrease of 223.77%.
The current valuation score of SANUWAVE Health Inc is 7.94. Its current P/E ratio is 2.36, which is 533.01% below the recent high of 14.94 and 3016.88% above the recent low of -68.85.
No earnings forecast score is currently available for SANUWAVE Health Inc. The Healthcare Equipment & Supplies industry's average is 7.76. The average price target is 47.00, with a high of 47.00 and a low of 47.00.
The current price momentum score of SANUWAVE Health Inc is 5.74. Currently, the stock price is trading between the resistance level at 5.11 and the support level at 3.96, making it suitable for range-bound swing trading.
The current institutional shareholding score of SANUWAVE Health Inc is 5.00. The latest institutional shareholding proportion is 63.34%, representing a quarter-over-quarter increase of 24.32%.
The current risk assessment score of SANUWAVE Health Inc is 2.16. The company's beta value is 1.35. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.